Loading...
•
Apr 30, 2025
Cooper Q2 2025 Earnings Report
Cooper reported higher revenue and EPS in Q2 2025, driven by strong performances in both CooperVision and CooperSurgical segments.
Key Takeaways
Cooper posted $1.002 billion in revenue and $87.7 million in net income for Q2 2025, with solid growth in both vision and surgical segments, and an improvement in gross and operating margins.
Revenue grew 6% YoY to $1.002 billion, driven by both CooperVision and CooperSurgical segments.
GAAP EPS remained flat at $0.44, while non-GAAP EPS rose to $0.96.
Operating income increased to $184.8 million, with operating margin improving to 18%.
Free cash flow was $18.1 million after capital expenditures of $78.1 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
CooperCompanies maintained strong guidance for FY2025 with expected revenue between $4.107B–$4.146B and non-GAAP EPS between $4.05–$4.11.
Positive Outlook
- Expected total revenue for FY2025 raised to $4.107–$4.146 billion.
- CooperVision revenue projected at $2.759–$2.786 billion.
- CooperSurgical expected to contribute $1.347–$1.359 billion.
- Non-GAAP EPS guidance of $4.05–$4.11 confirmed.
- Strong performance expected from daily silicone hydrogel lenses and surgical portfolio.
Challenges Ahead
- Guidance excludes potential acquisition-related charges.
- Non-GAAP EPS excludes restructuring and integration costs.
- Macroeconomic conditions may impact global operations.
- Foreign exchange volatility remains a concern.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...